Lipella Pharmaceuticals Inc. (LIPO) Operating margin 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) operating margin by fiscal year — reported operating income divided by reported revenue.
-947.2%FY2024 · since FY2021: -738.7% → -947.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -947.2% | +108.3 pp |
| FY2023 | -1055.6% | +350.7 pp |
| FY2022 | -1406.3% | -667.5 pp |
| FY2021 | -738.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LIPO financial trends
LIPO RevenueLIPO Net incomeLIPO Net marginLIPO Gross profitLIPO Gross marginLIPO Operating incomeLIPO Operating cash flowLIPO Free cash flowLIPO Capital expendituresLIPO Return on equityLIPO Stock buybacksLIPO Dividends paidLIPO Total assetsLIPO Total liabilitiesLIPO Shareholders’ equityLIPO overview →